The phenyl ester of CARBENICILLIN that, upon oral administration, is broken down in the intestinal mucosa to the active antibacterial. It is used for urinary tract infections.
Carfecillin has been studied across 9 research domains including 🧠 Focus & Attention, 🫁 Liver & Detox, 🫘 Kidney, 🦠 Gut & Microbiome, 🔥 Metabolic. The primary research focus is 🧠 Focus & Attention with 14% of studies addressing this area.
This evidence profile for Carfecillin is generated deterministically from 29 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.
Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.